Harmonic Bionics aims to empower patients and their care providers by designing intelligent technology that facilitates data-driven treatment for neurological and musculoskeletal movement impairments. Their flagship product, Harmony SHR™, is a bilateral upper extremity exoskeleton dynamically designed to provide unique value in three areas of practice: neuroscience and movement science research, movement disorder assessment, and rehabilitation.
Harmonic Bionics has announced that they have raised $3 million of venture funding from South Korea-based medical robot manufacturer Curexo, Inc. Harmonic Bionics will now assist with US promotion and business development for Curexo’s Morning Walk S200, a robotic gait rehabilitation system, and CUVIS-spine, a surgical spine robot.
Last year, the company raised a $7.42 million Series A from H Robotics, Bass Investment, and DSC Investment.